Clarity Pharmaceuticals Ltd.ASX: CU6

Diagnostic prostate cancer trial reaches recruitment target

Feb 9, 2023 at 4:09 AM UTC · Issued by Clarity Pharmaceuticals Ltd.

Clarity Pharmaceuticals Ltd has released a press release.

View Attachment